New Drug Molecule
| Product name | Pharmacopeia | Therapeutic Area |
|---|---|---|
| Lorlatinib | INN | Anti-Cancer |
| Ponatinib HCL | INN | Anti-Cancer |
| Obeticholic Acid | INN | Primary biliary cholangitis |
| Olaparib | INN | Anti-Cancer |
| Lenvatinib Mesylate | INN | Anti-Cancer |
| Cabozantinib S-Malate | INN | Anti-Cancer |
| Brigatinib | INN | Anti-Cancer |
| Capmatinib Hydrochloride Hydrate | INN | Anti-Cancer |
| Repotrectinib | INN | Anti-Cancer |
| Larotractinib Sulfate | INN | Anti-Cancer |
| Selpercatinib | INN | Anti-Cancer |
| Sorafenib Tosylate | INN | Anti-Cancer |
| Ruxolitinib Phosphate | INN | Anti-Cancer |
| Tucatinib | INN | Anti-Cancer |
| Venetoclax | INN | Anti-Cancer |
| Crizotinib | INN | Anti-Cancer |
| Cenobamate | INN | Anti-Convulsant |
| Tofacitinib Citrate | INN | Anti-Inflammatory |
| Betrixaban Maleate | INN | Anti-Thrombin |
| Sotorasib | INN | Anti-Cancer |
| Ivosidenib | INN | Anti-Cancer |
| Asciminib Hydrochloride | INN | Anti-Cancer |
| Filgotinib Maleate | INN | Anti-Inflammatory |
| Mobocertinib Succinate | INN | Anti-Cancer |
| Enasidenib Mesylate | INN | Anti-Cancer |
| Deucravacitinib | INN | Anti-Inflammatory |
| Gilteritinib Hemifumarate | INN | Anti-Cancer |
| Futibatinib | INN | Anti-Cancer |
| Entrectinib | INN | Anti-Cancer |
| Peficitinib Hydrobromide | INN | Anti-Rheumatic |
| Apalutamide | INN | Anti-Cancer |
| Olmasartan Medoxomil | INN | Cardiovascular |
| Indobufen | INN | Cardiovascular |
| Furosemide | INN | Diuretic |
| Tafamidis Meglumine | INN | Nervous System Disease |
| Diclofenac Epolamine | INN | Anti-Inflammatory |
| Flurbiprofen | INN | Anti-Inflammatory |
| Leucoson | INN | Anti-Biotic |
| Rotigotine | INN | Restless legs syndrome |
| Dabrafenib | INN | Anti-Cancer |
| Alectinib | INN | Anti-Cancer |